BioSpace News Archive

Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the pricing of an underwritten public offering of 8,110,000 shares of its common stock at a price to the public of $37.00 per share

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration (“FDA”) has granted tentative approval to TLANDO,

Sutro Biopharma, Inc. (Nasdaq: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced the pricing of an underwritten public offering of 6,000,000

Radium Incorporated in Waynesboro, Virginia was awarded a patent for their proprietary shielding solution branded as ClearView Radiation ShieldingTM in 2019.

As COVID-19 continues to spread across the United States and vaccine distribution begins, the National Pharmacy Technician Association (NPTA), a leading provider of ACPE-accredited continuing education and advanced training programs for certified pharmacy technicians, is announcing the launch of a nationally-recognized pharmacy technician administered immunization training program

CVS Health and the CVS Health Foundation announced a total of nearly $1.25 million in grants to help underserved communities in Ohio increase access to food and health care.

Bluejay Diagnostics, Inc. (Bluejay, Acton, MA ) today announced a collaboration agreement with Toray Industries, Inc. (Toray, Tokyo, Japan ) to develop a minimally-invasive, point-of-care test for COV

Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, today announced the company will participate in two upcoming investor conferences in December. 2020 RBC Capital Markets Healthcare Private Company Conference Format: Analyst-Led Fireside Chat Date: Tuesday, December 15, 2020 Time: 9:20 a.m. ET / 6:20 a.m. PT

OM1, a leading real-world, data, outcomes and technology company with a focus on chronic diseases, today announced the expansion of its Giant Cell Arteritis (GCA) registry.

Freespira, Inc., maker of the first FDA-cleared digital therapeutic that significantly reduces or eliminates symptoms of panic attacks, panic disorder and post-traumatic stress disorder (PTSD) in only 28 days, announced it has completed a $10 million capital raise led by Lightspeed Venture Partners.